HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy of alendronate in the treatment of the SAPHO syndrome.

AuthorsAntonella Fioravanti, Luca Cantarini, Luca Burroni, Maria Antonietta Mazzei, Luca Volterrani, Mauro Galeazzi
JournalJournal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases (J Clin Rheumatol) Vol. 14 Issue 3 Pg. 183-4 (Jun 2008) ISSN: 1536-7355 [Electronic] United States
PMID18525442 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Bone Density Conservation Agents
  • Alendronate
Topics
  • Acquired Hyperostosis Syndrome (drug therapy)
  • Adult
  • Alendronate (therapeutic use)
  • Bone Density Conservation Agents (therapeutic use)
  • Female
  • Humans

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: